XRCC1 and breast carcinoma: With changes in XRCC1 expression observed in some breast cancers, we hypothesized that XRCC1 expression level changes in TNBC could indicate BER defects which could be targeted to provide new treatment strategies for this aggressive breast cancer subtype.